Mylan Labs board rejects Icahn&#39;s takeover offer
639218
NEW YORK, November 22  - Mylan Labsâ (MYL.NYS) board of directors rejected investor Carl Icahnâs takeover bid today, terming his offer letter as a self serving publicity stunt, while reiterating the companyâs intention to proceed
491671
Applebee's International Inc.  said on Friday negotiations with hedge-fund investor Breeden Capital have failed to produce an agreement after Breeden rejected the restaurant chain's offer of two board seats.
768370
Billionaire investor Carl Icahn yesterday offered to purchase Mylan Laboratories for $20 per share, part of his plan to derail the Canonsburg generic drug maker&#39;s proposed acquisition of King Pharmaceuticals.
582905
The head of Mylan Laboratories Inc. lashed out at Wall Street financier Carl Icahn for trying to stop the company&#39;s acquisition of brand-name drug maker King Pharmaceuticals
609796
Despite concerns raised by an investor, Mylan Laboratories Inc. reaffirmed that its proposed acquisition of generic drug maker King Pharmaceuticals Inc.
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
425366
Pharmaceutical stocks were in the spotlight Thursday with news that investor Carl Icahn&#39;s was given a green light to buy a sizable chunk of Mylan Laboratories Inc.
754264
PHILADELPHIA, Aug 19  - Shares of Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) surged more than 10 percent on Thursday after billionaire investor Carl Icahn got federal regulatory approval to buy up 11.9 percent of ...
331749
Not buying it. Megafinancier Carl Icahn has made it clear: He&#39;s still opposed to Mylan Laboratories&#39; (nyse: MYL - news - people ) proposed acquisition of King Pharmaceuticals (nyse: KG - news - people ). Despite
483651
Motorola Inc.'s  board will not endorse a nomination of billionaire financier Carl Icahn to join the board, the company said in a document filed with regulators late on Friday.
131989
A Mylan Laboratories shareholder is suing the Canonsburg generic drug maker and its directors, saying they have failed their fiduciary obligations by not considering billionaire investor Carl Icahn&#39;s $20 per share offer for the company.
708938
Shareholders of Cablevision Systems Corp. rejected on Wednesday a $10.6 billion bid by the company's controlling shareholders, the Dolan family, to take the New York-area cable TV provider private.
271608
SL Green Realty said it would not raise its offer for Reckson Associates Realty to match a competing bid by a group led by the financier Carl C. Icahn.
143044
The London Stock Exchange PLC has received and rejected a bid proposal from Germany&#39;s main stock exchange, Deutsche Boerse AG , the exchanges said Monday.
741365
PITTSBURGH Mylan Laboratories again reiterated its commitment to the estimated four (B) billion dollar acquisition of brand-name drug maker King Pharmaceuticals despite Wall Street financier Carl Icahn upping his stake in the company.
763108
PeopleSoft&#39;s board unanimously rejected Oracle&#39;s $24-a-share offer as inadequate shortly after close of business in New York this evening.
226932
Billionaire financier Carl Icahn offered to buy Mylan Laboratories Inc., the largest US maker of generic medicines, for about $5.38 billion to block Mylan&#39;s proposed purchase of King Pharmaceuticals Inc.